SCHEDULE: Uzi Sofer Discloses 15.8% Stake in Alpha Tau Medical

Uzi Sofer, a citizen of Israel, has disclosed a beneficial ownership of 15.8% of Alpha Tau Medical Ltd.'s Ordinary Shares as of December 31, 2022.

Summary

• Uzi Sofer beneficially owns 13,702,361 Ordinary Shares of Alpha Tau Medical Ltd.
• This ownership represents 15.8% of the company's Ordinary Shares class.
• The beneficial ownership includes 2,187,047 Ordinary Shares underlying restricted stock units vested and stock options exercisable within 60 days of the filing date.
• The percentage of class is calculated based on 84,819,996 Ordinary Shares outstanding as of June 20, 2025, as disclosed in the Issuer's Form F-3 Registration Statement filed on June 23, 2025.
• Uzi Sofer holds sole voting power and sole dispositive power over all 13,702,361 shares.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of beneficial ownership. A significant insider stake is generally viewed as a positive signal of confidence, contributing to a slightly positive sentiment.

Positives

• A significant beneficial ownership stake of 15.8% by Uzi Sofer, an insider, may signal strong confidence in Alpha Tau Medical's future prospects and alignment of interests with shareholders.

Future Outlook

The filing is a beneficial ownership disclosure and does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

Alpha Tau Medical Ltd. operates in the medical technology sector, focusing on innovative treatments. This filing provides insight into the ownership structure by a key individual within the company.

Stakeholder Impact

• Shareholders may view the significant insider ownership by Uzi Sofer as a positive indicator of management's commitment and belief in the company's long-term value, potentially fostering investor confidence.

Key Dates

Keywords

Alpha Tau Medical, Uzi Sofer, Beneficial Ownership, Schedule 13G, Ordinary Shares, Medical Technology, Insider Ownership